Effects of Caffeine on Cerebral Blood Flow

May 10, 2023 updated by: Helder Santos, PhD, Escola Superior de Tecnologia da Saúde de Coimbra

Effects of Caffeine on Cerebral Blood Flow in Clinically Healthy Young People

The goal of this clinical trial is to evaluate in clinically healthy young people if:

  • after caffeine ingestion, there are variations in blood velocity of the middle cerebral arteries (VMCA),
  • this variation is dependent on the administered dose.

Transcranial Doppler ultrasonography was used to record blood VMCA in three groups of 15 clinically healthy young adults each - no caffeine, low caffeine (45 mg) and high caffeine group (120 mg). Transcranial Doppler ultrasonography provided simultaneous bilateral VMCA measurements while subjects performed functional tests (hyperventilation and hypoventilation orders) and three cognitive activities (Test 1, short-term remembering, Test 2, solving a vocabulary problem, and Test 3, solving a math problem) each in 31-second tests with 1-minute rest between them. Participants were assessed before and 30 minutes after caffeine ingestion.

Study Overview

Detailed Description

Were used in the study, Capsules dosed with 45mg and 120 mg of anhydrous caffeine and flour capsules as a placebo. In the preparation of the capsules, a semi-automatic capsulator No. 0 (Capsunorm® by Tecnyfarma®) were used, colorless hard gelatin capsules No. 0 by Acopharma® and anhydrous caffeine (Biochem®, C.A.S. 58-08-2).

Viasys Sonara transcranial Doppler unit and a 2 MHz probe were used to sample the middle cerebral artery at depths of 60 millimeters, using emission doppler pulsed performing spectral analysis in real time. Two probes (bilaterally) of 2MHz were placed at a depth between 55 and 60 mm, thus making it possible to analyse both middle cerebral arteries simultaneously.

Each participant was asked not to ingest caffeine and exercise vigorously for at least 12 hours before the assessment. In the case of smokers, they were also asked not to smoke for at least 2 hours before the evaluation. The laboratory had medium luminosity, silent and controlled temperature (23º/24ºC). To avoid inter-observer errors, all examinations were performed by the same investigator who was not aware of what dose was/had been administered to the participant.

Subjects were tested while seated in a reclining chair located in a dimly lit, sound-attenuated room and performed the activities with their eyes closed.

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Coimbra, Portugal, 3046-854
        • Coimbra Health School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • clinically healthy young people

Exclusion Criteria:

  • Individuals with hypertension, high cholesterol, diabetes, arrhythmias, carotid sinus syndrome, severe carotid stenosis and who were in an unstable clinical situation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: No caffeine
The control group took flour capsules.
Flour capsules as a placebo.
Experimental: Low caffeine
Group with relatively small amount of caffeine (45 mg) administered.
Capsules dosed with 45mg of anhydrous caffeine.
Experimental: High caffeine
Group with greater amount of caffeine (120 mg) administered.
Capsules dosed with 120mg of anhydrous caffeine.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Mean Velocity (Basal)
Time Frame: 30 minutes
Changes in Mean Velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Mean Velocity (Hypoventilation)
Time Frame: 30 minutes
By performing Hypoventilation, changes in Mean Velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Mean Velocity (Hyperventilation)
Time Frame: 30 minutes
By performing Hyperventilation, changes in Mean Velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Mean Velocity (Short-term memory test)
Time Frame: 30 minutes
With short-term memory test, changes in Mean Velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Mean Velocity (Vocabulary problem)
Time Frame: 30 minutes
With solving vocabulary problems, changes in Mean Velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Mean Velocity (Math problem.)
Time Frame: 30 minutes
With solving math problems, changes in Mean Velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Peak systolic velocity (Basal)
Time Frame: 30 minutes
Changes in Mean Velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Peak systolic velocity (Hypoventilation)
Time Frame: 30 minutes
By performing Hypoventilation, changes in Peak systolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Peak systolic velocity (Hyperventilation)
Time Frame: 30 minutes
By performing Hyperventilation, changes in Peak systolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Peak systolic velocity (Short-term memory test)
Time Frame: 30 minutes
With short-term memory test, changes in Peak systolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Peak systolic velocity (Vocabulary problems)
Time Frame: 30 minutes
With solving vocabulary problems, changes in Peak systolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Peak systolic velocity (Math problems)
Time Frame: 30 minutes
With solving math problems, changes in Peak systolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Vend-diastolic velocity (Basal)
Time Frame: 30 minutes
Changes in Mean Velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Vend-diastolic velocity (Hypoventilation)
Time Frame: 30 minutes
By performing Hypoventilation, changes in Vend-diastolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Vend-diastolic velocity (Hyperventilation)
Time Frame: 30 minutes
By performing Hyperventilation, changes in Vend-diastolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Vend-diastolic velocity (Short-term memory test)
Time Frame: 30 minutes
With short-term memory test, changes in Vend-diastolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Vend-diastolic velocity (Vocabulary problems)
Time Frame: 30 minutes
With solving vocabulary problems, changes in Vend-diastolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Vend-diastolic velocity (Math problems)
Time Frame: 30 minutes
With solving math problems, changes in Vend-diastolic velocity, measure in m/s from baseline to 30 minutes after caffeine ingestion.
30 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Heart Rate (Basal)
Time Frame: 30 minutes
Changes in Heart Rate, measure in bpm from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Heart Rate (Hypoventilation)
Time Frame: 30 minutes
By performing Hypoventilation, changes in Heart Rate, measure in bpm from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Heart Rate (Hyperventilation)
Time Frame: 30 minutes
By performing Hyperventilation, changes in Heart Rate, measure in bpm from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Heart Rate (Short-term memory test)
Time Frame: 30 minutes
With short-term memory test, changes in Heart Rate, measure in bpm from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Heart Rate (Vocabulary problems)
Time Frame: 30 minutes
With solving vocabulary problems, changes in Heart Rate, measure in bpm from baseline to 30 minutes after caffeine ingestion.
30 minutes
Changes in Heart Rate (Math problems)
Time Frame: 30 minutes
With solving math problems, changes in Heart Rate, measure in bpm from baseline to 30 minutes after caffeine ingestion.
30 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hélder Santos, PhD, Polytechnic Institute of Coimbra - Coimbra Health School

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2021

Primary Completion (Actual)

June 1, 2021

Study Completion (Actual)

June 1, 2021

Study Registration Dates

First Submitted

April 6, 2023

First Submitted That Met QC Criteria

May 10, 2023

First Posted (Actual)

May 19, 2023

Study Record Updates

Last Update Posted (Actual)

May 19, 2023

Last Update Submitted That Met QC Criteria

May 10, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular System

Clinical Trials on Placebo

3
Subscribe